Market Leadership Through customer loyalty with prominent brand identity, living improvement culture and evergreen leaders
Enabling anticipative, accurate & convenient health care for better life
NEO IMMUCOR FOR IRC
ENSEVAL MEDIKA PRIMA HELD NEO- IMMUCOR SOCIALIZATION FOR INDONESIA RED CROSS BLOOD BANK TRANSFUSION UNIT & HOSPITAL AT i3L JAKARTA
Located in Auditorium I3L (Indonesia International Institute for Life Sciences) Building 2nd floor, Pulomas- Jakarta, on Monday, December 15th, 2014. Enseval Medika Prima held th socialization of principal tools immunohematology from IMMUCOR - USA. The event was held as one of the efforts of PT. Enseval Medika Prima (EMP) with principal Immucor in introducing quality of products immunohematology’s instrumentation for Blood Donor Unit (UDD), PMI (Indonesian Red Cross) and Blood Bank of Hospital.
Immunohematology aspect of this role is required as part of efforts to improve on safety of blood transfusion, which is synonymous with the screening examination, only with the aim to prevent transmission of infection through blood transfusion. In fact, in a process that is both acute transfusion reactions and can also be fatal due to the incompatibility of blood type. In fact, the provision of suitable blood and after cross-matching test just still can cause transfusion reactions slowly at a later date. So the development of methods of examination procedures compatibility of blood before transfusion, it should be done, especially in the Central blood transfusion unit or UDD PMI, with antibody’ screening from the patients on a regular basis.
This event started around 09:00 am in the morning, attended by DR.dr. Yuyun SM Soedharmono (Director of UDD PMI), dr. Ria Syafitri M. Biomed (Deputy Director of Services PMI), while from EMP attended by Mr. Herman Widjaja (Director in Charge of EMP), Dr. George Kiongdo (Director of EMP), Mr Sudirman (BU / Head Hoslab), Mrs. Rita Meuraksa, Ms. Elizabeth F Sirait as Product Manager of Neo Immucor instrument , Mr. Denny Fitriansyah, and team HOSLAB & Scientific SCM EMP, and from principal represented by Mr. Ron Rogers MT (Immucor- USA), Tony Zhang (Immucor- China) as well as around 40 people invited, related to PMI and Hospitals, both from Jakarta and outside Jakarta.
Prof. Niclas Adler, PhD, as President of i3L attended and also presented on the profile and activities of I3L Institute.
This event activity program began with a traditional dance of Jakarta, as well as a open speech by Mr Herman Widjaja, Dr. George Kiongdo , both from EMP, and also DR.dr. Yuyun SM Soedharmono (Director of Central PMI - UDD).
As the main topic on first session, DR.dr. Yuyun SM Soedharmono, MSc give presentation related to 'Pre-transfusion Current Update Test'. Then proceed by dr. Ria Syafitri M. Biomed who brought the topic of 'Evaluation of fully automatic Immucor- NEO & Reagents at IRC Central Blood Transfusion Services', Mr. Ron Rogers as speaker of principal Immucor then introduce and give a presentation related to 'Immucor Automation and Solid phase testing'.
It ended with a live demo-NEO Immucor products directly, which was delivered by Mr. Tony Zhang (China). All participants were enthusiastic to follow this socialization and to introduce the tool of immunohematology who have passed the evaluation by the central PMI. Many questions have raised by the participants during these presentations and then took place by some discussions with audience.
About IMMUCOR, USA Immucor USA was established in 1987 by a group of some researchers in the field of blood bank reagents industry in Atlanta, USA. Currently, Immucor is the number One supplier in the regional aspect of immunohematology in North America, and also includes three major suppliers in the worldwide. Instrumentation and reagents produced by Immucor has obtained a license from the US FDA and the supervision Agency of IVDD CE (Europe).
From the aspect of instrumentation or equipment, Immucor also has a comprehensive products, starting with ABS Precis ( 1997) Galileo ( 2002), then Echo in 2007, until NEO in year of 2010. As for reagents and assay, Immucor business focused products in the field of cross-matching test, transfusion and transplantation process both the donor & recipient. Type and range of products of blood bank owned by Immucor is varied and quite a lot of, among others, the reagent antisera (ImmuClone), reagent of red blood cells (Panoscreen), Solid Phase Test Method namely Capture, and most recently the blood group genotyping Bio Array Beadchip, etc.
As the play on global market for blood transfusion, Immucor continuously committed to providing automation products in immunohematology aspects aimed at improving the effectiveness and safety of blood for donors and recipients.